NGM Biopharmaceuticals Inc logo

NGM Biopharmaceuticals Inc

NAS:NGM (USA)  
$ 1.54 0 (0%) 08:08 PM EST
At Loss
P/B:
0.86
Market Cap:
$ 128.53M
Enterprise V:
$ -36.13M
Volume:
-
Avg Vol (2M):
1.28M
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
1.28M

Business Description

Description
NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's products include, NGM313 (MK-3655), NGM120, NGM621, and NGM395 among others. These are focused on NASH, diabetes, oncology, AMD and metabolic disease.
Name Current Vs Industry Vs History
Cash-To-Debt 104.41
Equity-to-Asset 0.88
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.98
Distress
Grey
Safe
Beneish M-Score -6.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.43
9-Day RSI 43.66
14-Day RSI 48.54
6-1 Month Momentum % 19.53
12-1 Month Momentum % -60.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.79
Quick Ratio 7.79
Cash Ratio 7.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.5
Shareholder Yield % 3.57

Financials (Next Earnings Date:2024-05-03 Est.)

NGM's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NGM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NGM Biopharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.417
EPS (TTM) ($) -1.73
Beta 0.57
Volatility % 107.11
14-Day RSI 48.54
14-Day ATR ($) 0.048691
20-Day SMA ($) 1.555
12-1 Month Momentum % -60.05
52-Week Range ($) 0.6002 - 4.69
Shares Outstanding (Mil) 83.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NGM Biopharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

NGM Biopharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

NGM Biopharmaceuticals Inc Frequently Asked Questions

What is NGM Biopharmaceuticals Inc(NGM)'s stock price today?
The current price of NGM is $1.54. The 52 week high of NGM is $4.69 and 52 week low is $0.60.
When is next earnings date of NGM Biopharmaceuticals Inc(NGM)?
The next earnings date of NGM Biopharmaceuticals Inc(NGM) is 2024-05-03 Est..
Does NGM Biopharmaceuticals Inc(NGM) pay dividends? If so, how much?
NGM Biopharmaceuticals Inc(NGM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1